Neurocentrx Pharma
PrivateLast Round
Series A
Sep 23, 2025
Total Funding Raised
$5M
Company Overview
Neurocentrx Pharma is a biopharmaceutical company developing oral ketamine formulations designed to treat patients with mood disorders and other neurological conditions.
Sector
Healthcare & Life Sciences
Verticals
Mental Health, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts, Hardware + Subscription
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Neurocentrx Pharma Comps
Public and private peers based on sector, stage, and business model.
Neurocentrx Pharma Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Sep 23, 2025 | ||||
| Seed | Sep 23, 2025 | ||||
| VC Round | May 12, 2022 |
Neurocentrx Pharma Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| o2h ventures | VC Round |
| Equity Gap | VC Round |
| Meltwind Advisory | VC Round |
| Old College Capital | VC Round |
| Scottish Investment Bank (Scottish Enterprise) | VC Round |
| Wellcome Trust | Seed |
Neurocentrx Pharma Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Neurocentrx Pharma's valuation, stock price, and market status.
